Starling Oncology, Inc. STLN
3.75 USD -0.45 (-10.71%)
At closeNov 12, 2026, 7:51 PM EST
3.75 0.00 -0.01%
After hours · Nov 12, 7:51 PM ET
3.67 Day range 4.24
2.32 52-week range 7.13
- YTD
- +5.34%
- 1 year
- +9.33%
STLN revenue history
Revenue is income from the company’s ordinary business activities.
502,729,000 USD
FY 2025 · Period ended
Coverage: complete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | 502,729,000 | 109,317,000 | 27.79% |
| FY 2024 | 2024-12-31 | 393,412,000 | 69,173,000 | 21.33% |
| FY 2023 | 2023-12-31 | 324,239,000 | 71,756,000 | 28.42% |
| FY 2022 | 2022-12-31 | 252,483,000 | 49,480,000 | 24.37% |
| FY 2021 | 2021-12-31 | 203,003,000 | 15,488,000 | 8.26% |
| FY 2020 | 2020-12-31 | 187,515,000 | 32,109,816 | 20.66% |
| FY 2019 | 2019-12-31 | 155,405,184 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-08-11T06:01:46.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.